Kezar Life Sciences Investor Relations Material
Latest events
Q4 2024 & Study Result
Kezar Life Sciences
Q2 2025
13 Aug, 2025
Corporate Presentation
1 Jun, 2025
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Kezar Life Sciences Inc
Access all reports
Kezar Life Sciences Inc. is a biotechnology company focused on developing therapies for autoimmune diseases and cancer. The company specializes in small-molecule drug candidates targeting protein homeostasis and immune system regulation. Its research and development efforts aim to advance treatments for conditions such as lupus nephritis and other immune-mediated disorders through clinical trials. The company is headquartered in South San Francisco, California, and its shares are listed on the NASDAQ.
)
)
)